Trade AMGN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Amgen Inc. (AMGN) is trading at US$382.30, down 2.29% today as of Sep 10, 13:43 EDT. The company has a market capitalisation of US$237.52B. Over the past 52 weeks, AMGN has traded between US$269.77 and US$447.03. On Syfe you can trade AMGN with $0 commission and add it to your watchlist.
| Previous close | US$391.27 |
|---|---|
| Market cap | US$237.52B |
| P/E ratio | 15.92 |
| 52-week range | US$269.77 – US$447.03 |
| Dividend yield | 2.55% |
| Volume | 2.83M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Amgen Inc.
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Year: 1983
Amgen Inc. (AMGN) stock is trading at US$382.30, -2.29% from the previous close of US$391.27.
The market cap for Amgen Inc. (AMGN) stock is approximately US$237.52B.
The price-to-earnings ratio for Amgen Inc. (AMGN) is 15.92, based on the latest reported earnings.
The 52-week high for Amgen Inc. (AMGN) stock is US$447.03.
The 52-week low for Amgen Inc. (AMGN) stock is US$269.77.
Yes, Amgen Inc. (AMGN) pays a dividend. The trailing 12-month dividend yield is 2.55%.
Stay on top of AMGN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
